FAIR VALUE DISCLOSURES - Narrative (Details) - USD ($)		3 Months Ended
	Dec. 12, 2023	Mar. 31, 2024	Mar. 31, 2023	Mar. 28, 2024	Jan. 24, 2024	Dec. 31, 2023
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Money market funds		$ 174,316,000				$ 194,841,000
Interest rate swap		$ 7,654,000				6,236,000
Achievement of milestones payment period		24 months
Payments on contingent consideration		$ 12,500,000	$ 0
Contingent consideration		11,600,000				24,000,000.0
CG Oncology
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Shares held (in shares)					219,925
Value of shares held		9,700,000
Closing price				$ 43.90
Novitium
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Additional contingent consideration		46,500,000
Payments on contingent consideration	$ 12,500,000
Contingent consideration		$ 11,574,000				$ 23,984,000